Celcuity (CELC) Cash & Equivalents (2016 - 2025)
Celcuity (CELC) reported Cash & Equivalents of $441.5 million for Q4 2025, up 1862.22% on a YoY basis from $22.5 million in Q4 2024, and up 494.6% quarter-over-quarter from $74.3 million in Q3 2025.
Celcuity (CELC) Cash & Equivalents (2016 - 2025) Analysis & Trends
Celcuity has reported Cash & Equivalents for 10 years, with the latest figure at $441.5 million in Q4 2025.
- For the quarter ending Q4 2025, Cash & Equivalents rose 1862.22% year-over-year to $441.5 million; the trailing twelve-month figure through Dec 2025 stood at $441.5 million (up 1862.22% YoY), and the FY2025 full-year result was $441.5 million, up 1862.22% from the prior year.
- Cash & Equivalents for Q4 2025 stood at $441.5 million, up from $74.3 million in the prior quarter.
- The five-year high for Cash & Equivalents was $441.5 million in Q4 2025, with the low at $12.6 million in Q3 2024.
- Historically, Cash & Equivalents has averaged $63.8 million across 5 years, with a median of $34.3 million in 2021.
- Annual changes were most pronounced in 2022 — Cash & Equivalents tumbled 70.85% — and 2025, when it jumped 1862.22%.
- Celcuity's Cash & Equivalents stood at $84.3 million in 2021, then sank by 70.85% to $24.6 million in 2022, then grew by 24.79% to $30.7 million in 2023, then declined by 26.62% to $22.5 million in 2024, then jumped by 1862.22% to $441.5 million in 2025.
- The last three Cash & Equivalents figures came in at $441.5 million (Q4 2025), $74.3 million (Q3 2025), and $46.4 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | 32.30 Mn |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 1.91 Mn |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 286.70 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | 2.77 Mn |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | 18.44 Mn |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | 7.15 Mn |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 5.49 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | 558.94 Mn |
| 10 | Celcuity | 4.14 Bn | 3.42 Bn | - | 441.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 441.50 Mn |
| Sep 30, 2025 | 74.25 Mn |
| Jun 30, 2025 | 46.35 Mn |
| Mar 31, 2025 | 16.48 Mn |
| Dec 31, 2024 | 22.50 Mn |
| Sep 30, 2024 | 12.60 Mn |
| Jun 30, 2024 | 30.46 Mn |
| Mar 31, 2024 | 31.21 Mn |
| Dec 31, 2023 | 30.66 Mn |
| Sep 30, 2023 | 25.76 Mn |
| Jun 30, 2023 | 32.24 Mn |
| Mar 31, 2023 | 33.64 Mn |
| Dec 31, 2022 | 24.57 Mn |
| Sep 30, 2022 | 57.48 Mn |
| Jun 30, 2022 | 66.91 Mn |
| Mar 31, 2022 | 78.30 Mn |
| Dec 31, 2021 | 84.29 Mn |
| Sep 30, 2021 | 90.37 Mn |
| Jun 30, 2021 | 41.64 Mn |
| Mar 31, 2021 | 34.94 Mn |